Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| abrdn Healthcare InvestorsHQH · Entity 8816 | Director | January 25, 2018 | January 29, 2018 |
| abrdn Healthcare Opportunities FundTHQ · Entity 5102 | Director | January 25, 2018 | January 29, 2018 |
| abrdn Life Sciences InvestorsHQL · Entity 8835 | Director | January 25, 2018 | January 29, 2018 |
| abrdn World Healthcare FundTHW · Entity 5390 | Director | April 06, 2021 | April 08, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
abrdn Healthcare Investors
Report date January 25, 2018 · Filed January 29, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Shares of Beneficial InterestSEC Table I · non-derivative | Direct | 1,100 |
Reported balance
After 2018-01-25 transaction · row 1
1 source rowRow 1 · 2018-01-25 · Purchase · Acquired 1,100 · Balance 1,100 |
abrdn Healthcare Opportunities Fund
Report date January 25, 2018 · Filed January 29, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Shares of Beneficial InterestSEC Table I · non-derivative | Direct | 1,400 |
Reported balance
After 2018-01-25 transaction · row 1
1 source rowRow 1 · 2018-01-25 · Purchase · Acquired 1,400 · Balance 1,400 |
abrdn Life Sciences Investors
Report date January 25, 2018 · Filed January 29, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Shares of Beneficial InterestSEC Table I · non-derivative | Direct | 1,300 |
Reported balance
After 2018-01-25 transaction · row 1
1 source rowRow 1 · 2018-01-25 · Purchase · Acquired 1,300 · Balance 1,300 |
abrdn World Healthcare Fund
Report date April 06, 2021 · Filed April 08, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Shares of Beneficial InterestSEC Table I · non-derivative | Direct | 2,400 |
Reported balance
After 2021-04-06 transaction · row 1
1 source rowRow 1 · 2021-04-06 · Other · Acquired 600 · Balance 2,400 |
| Subscription RightsSEC Table II · derivative / convertible security · Conversion / exercise price $14.26 · Expires 2021-04-06 | Direct | 0 |
Reported balance
After 2021-04-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-04-06 · Other · Disposed 1,800 · Balance 0 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 06, 2021 Filed Apr 8, 2021 20:23 UTC | abrdn World Healthcare Fund THW · Entity 5390 | OtherSubscription Rights · Derivative | 1,800 | $0.00 Strike: $14.26 | $0.00 |
DisclosureSEC source: 0001104659-21-048068 · tm2111500-1_4seq1.xml · derivative · entry 2 Kent Thomas M · CIK 0001728564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Shares of Beneficial Interest · 600 shares Expires 2021-04-06 Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 20:23 UTC | abrdn World Healthcare Fund THW · Entity 5390 | OtherShares of Beneficial Interest | 600 | $14.26 | $8,557.20 |
DisclosureSEC source: 0001104659-21-048068 · tm2111500-1_4seq1.xml · nonDerivative · entry 1 Kent Thomas M · CIK 0001728564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,400 Read SEC document |
| January 25, 2018 Filed Jan 29, 2018 14:45 UTC | abrdn Healthcare Investors HQH · Entity 8816 | PurchaseShares of Beneficial Interest | 1,100 | $24.19 | $26,604.82 |
DisclosureSEC source: 0001728564-18-000005 · primary_doc.xml · nonDerivative · entry 1 Kent Thomas M · CIK 0001728564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,100 Read SEC document |
| January 25, 2018 Filed Jan 29, 2018 15:07 UTC | abrdn Life Sciences Investors HQL · Entity 8835 | PurchaseShares of Beneficial Interest | 1,300 | $21.04 | $27,347.97 |
DisclosureSEC source: 0001728564-18-000006 · primary_doc.xml · nonDerivative · entry 1 Kent Thomas M · CIK 0001728564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 Read SEC document |
| January 25, 2018 Filed Jan 29, 2018 15:19 UTC | abrdn Healthcare Opportunities Fund THQ · Entity 5102 | PurchaseShares of Beneficial Interest | 1,400 | $18.50 | $25,903.36 |
DisclosureSEC source: 0001728564-18-000007 · primary_doc.xml · nonDerivative · entry 1 Kent Thomas M · CIK 0001728564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,400 Read SEC document |
| January 25, 2018 Filed Jan 29, 2018 15:31 UTC | abrdn World Healthcare Fund THW · Entity 5390 | PurchaseShares of Beneficial Interest | 1,800 | $14.52 | $26,128.44 |
DisclosureSEC source: 0001728564-18-000008 · primary_doc.xml · nonDerivative · entry 1 Kent Thomas M · CIK 0001728564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,800 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.